Delivery Order SPE2DB24D8001-SPE2DB24FKYTL
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $18,921.34 firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the provision of Stelara 90 mg/mL syringes. The contract has an ultimate completion date of July 10, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA, supplying a wide range of pharmaceutical products, medical supplies, and healthcare equipment in...
This is a $12,846.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Stelara 90 mg/mL syringes. The contract has no set-aside designation and is awarded under DLA's pharmaceutical supply chain contracts to support medical supply operations for the U.S. Armed Forces. Dakota Drug, Inc. is an experienced prime contractor to DLA, specializing in providing a wide range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Stelara 90 mg/mL syringes, with a completion date of November 2, 2023, and a ceiling value of $8,600.28. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,586.33, is for the provision of Stelara 90 mg/mL syringes, which are a biologic medication used to treat autoimmune conditions. The contract has an ultimate completion date of June 18, 2024 and was awarded on June 17, 2024. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,388.98 contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through March 29, 2024. This contract does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA Troop Support Medical, having provided a...
This is a $11,114.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of May 2, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, with a significant single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $10,986.80 contract is for the supply of STELARA 90 MG/ML syringes, a biologic medication used to treat rheumatoid arthritis and other medical conditions. This delivery order is issued against Dakota Drug, Inc.'s blanket purchase agreement and other DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,085.39 contract is for the provision of STELARA 90 MG/ML syringes, a biologic medication used to treat autoimmune conditions. The award is under a larger single-award Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT Generation V...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product STELARA 90 MG/ML SYRINGE. The contract has a firm fixed price ceiling value of $9,397.47 and a period of performance extending until February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,866.34 firm-fixed-price contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance ending on September 22, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the Department of...